Skip to main content
. 2015 Aug 28;21(2):104–111. doi: 10.6118/jmm.2015.21.2.104

Table 3. Baseline characteristics of transdermal hormone therapy group by additional protesterone.

graphic file with name jmm-21-104-i003.jpg

Data are presented as mean ± standard deviation or number (%)

*P < 0.05 indicates significant difference between two groups